Means for diagnosing, predicting or monitoring pneumocystis pneumonia
Abstract
The application relates to means for diagnosing, predicting or monitoring Pneumocystis pneumonia (PCP). The means of the application are also suitable for determining or predicting the efficacy of a drug or treatment against PCP in a human patient. The means of involve the detection and/or quantification, more particularly the quantification, of the RNA transcripts of two different P. jirovecii mitochondrial genes. The first of said two P. jirovecii mitochondrial genes is the P. jirovecii gene, the sequence of which codes for the Cytb protein or the P. jirovecii mitochondrial Small Sub-Unit (mtSSU) gene. The second of said two P. jirovecii mitochondrial genes is a P. jirovecii gene, the sequence of which transcribes into a P. jirovecii ribosomal RNA, e.g., be the mitochondrial P. jirovecii Large Sub-Unit (mtLSU) gene.
Claims
exact text as granted — not AI-modified1 - 33 . (canceled)
34 . A kit suitable for diagnosing or predicting PneumoCystis Pneumonia (PCP) in a human patient, who is a Pneumocystis jirovecii carrier, or for determining or predicting the efficacy of a drug or treatment against PCP in a human patient, who is a Pneumocystis jirovecii carrier, wherein said kit comprises a reverse transcriptase, a polymerase, and oligonucleotides;
wherein said oligonucleotides comprise a first primer pair and a second primer pair and/or a first probe and a second probe; wherein said first primer pair and/or said first probe specifically hybridizes to the cDNA reverse transcripts of the RNA transcripts of a first P. jirovecii mitochondrial gene; wherein said second primer pair and/or said second probe specifically hybridizes to the cDNA reverse transcripts of the RNA transcripts of a second P. jirovecii mitochondrial gene; and wherein the first and the second P. jirovecii mitochondrial genes are different.
35 . The kit of claim 34 , wherein the first mitochondrial gene codes for the Cytb protein.
36 . The kit of claim 34 , wherein the first mitochondrial gene transcribes into a P. jirovecii ribosomal RNA.
37 . The kit of claim 35 , wherein the second mitochondrial gene transcribes into a P. jirovecii ribosomal RNA.
38 . The kit of claim 36 , wherein the second mitochondrial gene transcribes into a P. jirovecii ribosomal RNA.
39 . The kit of claim 36 , wherein the first mitochondrial gene is the P. jirovecii mitochondrial Small Sub-Unit (mtSSU) gene.
40 . The kit of claim 37 , wherein the second mitochondrial gene is the mitochondrial P. jirovecii Large Sub-Unit (mtLSU) gene.
41 . The kit of claim 38 , wherein the second mitochondrial gene is the mitochondrial P. jirovecii Large Sub-Unit (mtLSU) gene.
42 . The kit of claim 35 , wherein the first P. jirovecii mitochondrial gene comprises the sequence of SEQ ID NO: 29 or an RNA sequence that is of the same length as SEQ ID NO: 29 and is at least 95% identical to SEQ ID NO: 29.
43 . The kit of claim 36 , wherein when the first P. jirovecii mitochondrial gene comprises the sequence of SEQ ID NO: 14, SEQ ID NO: 19 or SEQ ID NO: 24, or an RNA sequence that is of the same length as SEQ ID NO: 14, SEQ ID NO: 19, or SEQ ID NO: 24 and is at least 95% identical to SEQ ID NO: 14, SEQ ID NO: 19 or SEQ ID NO: 24, respectively.
44 . The kit of claim 37 , wherein the second P. jirovecii mitochondrial gene is comprises the sequence of SEQ ID NO: 9, or an RNA sequence that is of the same length as SEQ ID NO: 9 and is at least 95% identical to SEQ ID NO: 9.
45 . The kit of claim 38 , wherein the second P. jirovecii mitochondrial gene is comprises the sequence of SEQ ID NO: 9, or an RNA sequence that is of the same length as SEQ ID NO: 9 and is at least 95% identical to SEQ ID NO: 9.
46 . The kit of claim 34 , wherein when the first P. jirovecii mitochondrial gene is the gene which codes for the Cytb protein, the quantification of the RNA transcripts of the first P. jirovecii mitochondrial gene is performed using a first probe that hybridizes to SEQ ID NO: 30 or to the complementary sequence thereof, without hybridizing to any of SEQ ID NO: 1, the sequence complementary to SEQ ID NO: 1, SEQ ID NO: 2 and the sequence complementary to SEQ ID NO: 2; and
wherein when the first P. jirovecii mitochondrial gene is the mitochondrial P. jirovecii Small Sub-Unit (mtSSU) gene, the quantification of the RNA transcripts of the first P. jirovecii mitochondrial gene is performed using a first probe that hybridizes to SEQ ID NO: 15, or to the sequence complementary to SEQ ID NO: 15, or to SEQ ID NO: 20, or to the sequence complementary to SEQ ID NO: 20, or to SEQ ID NO: 25, or to the sequence complementary to SEQ ID NO: 25, without hybridizing to any of SEQ ID NO: 3, the sequence complementary to SEQ ID NO: 3, SEQ ID NO: 1 and the sequence complementary to SEQ ID NO: 1; and wherein when the second P. jirovecii mitochondrial gene is the mitochondrial P. jirovecii Large Sub-Unit (mtLSU) gene, the quantification of the RNA transcripts of the second P. jirovecii mitochondrial gene is performed using a second probe that hybridizes to SEQ ID NO: 10 or to the sequence complementary to SEQ ID NO: 10, without hybridizing to any of SEQ ID NO: 3, the sequence complementary to SEQ ID NO: 3, SEQ ID NO: 2 and the sequence complementary to SEQ ID NO: 2.
47 . The kit of claim 46 , wherein the second probe comprises SEQ ID NO: 13.
48 . The kit of claim 46 , comprising a primer comprising SEQ ID NO: 11 and a primer comprising SEQ ID NO: 12.Join the waitlist — get patent alerts
Track US2022119886A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.